Skip to Content

M 515 (Mirtazapine 15 mg)

Pill with imprint M 515 is Beige, Round and has been identified as Mirtazapine 15 mg. It is supplied by Mylan Pharmaceuticals Inc..

Mirtazapine is used in the treatment of major depressive disorder; anxiety; insomnia; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 515

Mirtazapine

Imprint:
M 515
Strength:
15 mg
Color:
Beige
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Tetracyclic antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
silicon dioxide
croscarmellose sodium
FD&C Blue No. 2
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0086 UDL Laboratories Inc.
54569-5895 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide